Two significant programs that invested in research on diabetes, dementia, obesity and kidney disease have ended since the ...

For a disease afflicting 35.5 million people in the U.S., chronic kidney disease flies under the radar. Only half the people ...

New UCLA research conducted using mouse models and human genetic data has uncovered a critical factor that determines how ...

Chronic Kidney Disease (CKD) affects approximately 15% of U.S. adults and as many as 9 in 10 with CKD are unaware they have ...

Tirzepatide offers a promising treatment for patients with obesity, chronic kidney disease, and heart failure, improving both ...

Chicago: For a disease afflicting 35.5 million people in the US, chronic kidney disease flies under the radar. Only half the people who have it are formally diagnosed. The consequences of advanced ...

Frequent consumption of bubbly and sugary drinks could be a contributing factor for any number of reasons that damage kidney ...

Deficiency of the pancreatic progenitor cell differentiation and proliferation factor gene was identified as a risk factor ...

Results from the SUMMIT trial suggest that tirzepatide is as effective in preventing heart failure events in those with ...

In March 2025, Shandong Suncadia Medicine Co., Ltd. conducted a phase II Clinical Study of Efficacy and Safety of HRS-1780 ...